Literature DB >> 12069181

Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days.

Daniel G Remick1, Gerald R Bolgos, Javed Siddiqui, Jungsoon Shin, Jean A Nemzek.   

Abstract

Virtually of the all recent therapeutic interventions for treating sepsis have failed to improve survival. One potential explanation is that the heterogeneity of the immune response to the septic challenge is such that only a portion of the patients die as a result of excessive inflammation. The clinical trials lacked power because traditional measurements do not accurately identify these patients. Previous work has shown that higher levels of interleukin (IL)-6 are found in those mice that die from septic peritonitis; therefore, we sought to determine whether IL-6 measured 6 h after surgery could predict outcome. Adult, female BALB/c mice (n = 79) were subjected to cecal ligation and puncture with a 21-gauge needle and treated with imipenem in D5W every 12 h for 5 days, resulting in a homogenous population at the outset. Six hours after surgery, 20 microL of blood was obtained from the tail vein to measure IL-6. Mortality was followed for 21 days. Overall 3-day survival was 77%, and 21-day mortality was 56%. Plasma IL-6 levels >2,000 pg/mL were determined to predict mortality within the first 3 days with a sensitivity of 58% and specificity of 97%. To further refine the mortality prediction, body weight and a complete blood count were performed 24 hours after cecal ligation and puncture. Discriminate analysis indicated that a weighted formula combining body mass, lymphocyte, and platelet count would predict death with sensitivity of 83% and a specificity of 79%. We tested the value of the IL-6 prediction by surgically resecting the cecum in those animals with IL-6 > 2000 pg/mL, which resulted in a significant improvement in survival. These data demonstrate that IL-6 measured 6 h after injury accurately predicts mortality resulting from experimental sepsis. This measurement may be determined quickly so that therapy may be targeted only to those individuals at significant risk of dying and initiated within sufficient time to be effective.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069181     DOI: 10.1097/00024382-200206000-00004

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  171 in total

Review 1.  Jaks, STATs, Cytokines, and Sepsis.

Authors:  Melanie J Scott; Christopher J Godshall; William G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis.

Authors:  Laura Brudecki; Donald A Ferguson; Deling Yin; Gene D Lesage; Charles E McCall; Mohamed El Gazzar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation.

Authors:  Hongkuan Fan; Donald Wong; Sarah H Ashton; Keith T Borg; Perry V Halushka; James A Cook
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

4.  Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.

Authors:  Sachin S Kale; Sachin Yende
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

5.  Effects of aging on the immunopathologic response to sepsis.

Authors:  Isaiah R Turnbull; Andrew T Clark; Paul E Stromberg; David J Dixon; Cheryl A Woolsey; Christopher G Davis; Richard S Hotchkiss; Timothy G Buchman; Craig M Coopersmith
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

Review 6.  Bench-to-Bedside: A Translational Perspective on Murine Models of Sepsis.

Authors:  Anthony J Lewis; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2018-02-02       Impact factor: 2.150

7.  Chronic sepsis mortality characterized by an individualized inflammatory response.

Authors:  Marcin F Osuchowski; Kathy Welch; Huan Yang; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

8.  Intestine-specific overexpression of IL-10 improves survival in polymicrobial sepsis.

Authors:  Saju Rajan; Dinesh Vyas; Andrew T Clark; Cheryl A Woolsey; Jessica A Clark; Richard S Hotchkiss; Timothy G Buchman; Craig M Coopersmith
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

9.  Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes.

Authors:  Asha Jacob; Marissa L Steinberg; Juntao Yang; Weifeng Dong; Youxin Ji; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-10

10.  The melanocortin 1 receptor (MC1R) inhibits the inflammatory response in Raw 264.7 cells and atopic dermatitis (AD) mouse model.

Authors:  Wei Chen; Jianping Li; Hai'e Qu; Zhou Song; Zhanqing Yang; Jinlong Huo; Huaizhi Jiang; Qinghua Huang; Meixia Huo; Bo Liu; Qiaoling Zhang
Journal:  Mol Biol Rep       Date:  2012-10-23       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.